Comment on 'Efficacy and safety of vismodegib in basosquamous carcinoma: insights from a retrospective study including 18 patients': basosquamous carcinoma at the crossroads: histological ambiguity, treatment potential and the path to clinical consensus.

IF 2.8 4区医学 Q1 DERMATOLOGY

Clinical and Experimental Dermatology Pub Date : 2025-08-22 DOI:10.1093/ced/llaf195

Aparna Potluru, Daryl Teo, Pick Ngor-Woo

引用次数: 0

查看原文本刊更多论文

“维莫地吉治疗基底鳞癌的疗效和安全性：来自18例患者的回顾性研究的见解”——十字路口的基底鳞癌：组织学模糊、治疗潜力和临床共识之路。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Experimental Dermatology 医学-皮肤病学

CiteScore

3.20

自引率

2.40%

发文量

389

审稿时长

3-8 weeks

期刊介绍： Clinical and Experimental Dermatology (CED) is a unique provider of relevant and educational material for practising clinicians and dermatological researchers. We support continuing professional development (CPD) of dermatology specialists to advance the understanding, management and treatment of skin disease in order to improve patient outcomes.